Background. Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-Kp) has emerged globally over the last decade as a major nosocomial pathogen that threatens patient care. These highly resistant bacteria are mostly associated with a single Kp clonal group, CG258, but the reasons for its host and hospital adaptation remain largely unknown.
The increasing incidence of extended-spectrum β-lactamase-and carbapenemase-producing strains of Klebsiella pneumoniae (Kp) in healthcare facilities is a cause of global concern. In several countries including Greece, Italy, Israel, and the United States, the rate of infections with Kp resistant to all commercially available antibiotics is worryingly growing [1] [2] [3] [4] [5] . Most of these isolates are resistant to all β-lactams due to the production of a class A carbapenemase named KPC and can also be resistant to other antibiotics of last resort such as tigecylin [6] and colistin [7] . The worldwide dissemination of KPC-Kp is mainly associated with the spread of a single clonal group designated CG258 [1, 8, 9] .The evolutionary success of CG258 in combination with KPC is not yet fully understood. Several factors might have an impact on the global dissemination of a clone, such as increased pathogenicity, high transmissibility, and/or increased duration of colonization [9] . Analysis of KPC-Kp sequence type (ST) 258 outbreaks indicated that this clone can be easily transmitted between patients for several months following the identification of the initial index case [8] . However, little is known about the outcome of KPC-Kp fecal carriers and the duration of carriage, which are determining transmission factors. Some studies indicate that patients can exhibit spontaneous decolonization within 6 months after KPC-Kp acquisition [10] . In contrast, there have been reports of carriage >1 year [8, 10, 11] .
Here we analyzed the evolution of a KPC-Kp ST258 strain that colonized a patient over 4.5 years. This strain underwent considerable genetic and phenotypic diversification to adapt to antibiotic treatments and to promote virulence. These results highlight the capacity of adaption of a KPC-Kp ST258 strain that may contribute to its propensity to sustainably colonize patients and persist in healthcare institutions.
Bacterial Strains
Strain Kp BIC-1 transmitted to the patient was recovered from a contaminated endoscope [12, 13] . Strains S1-S17 were isolated from different body sites and are summarized in Table 1 . Kp CIP 53153, YC2004 (KPC-Kp ST258) [14] , and KN633 (KPC-Kp ST338) [14] are isolates susceptible to colistin used as control in quantitative reverse-transcription polymerase chain reaction (qRT-PCR) experiments. Kp LM21 was used as positive control in biofilm formation [15] . Electrocompetent Escherichia coli TOP10 (ThermoFisher, Villebon Sur Yvette, France) was used as a recipient in electroporation experiments.
Antimicrobial Susceptibility Testing
Minimum inhibitory concentrations (MICs) for carbapenems (imipenem, ertapenem, and meropenem), aminoglycosides (gentamicin, amikacin, tobramycin, and netilmicin), and tigecycline were determined using Etest strips (bioMérieux) on Mueller-Hinton agar plates (Bio-Rad). The MICs for colistin were determined by broth culture microdilution in triplicate. Results were interpreted according to the European Committee on Antimicrobial Susceptibility Testing guidelines (www.eucast.org).
Whole-Genome Sequencing and Bioinformatics Analysis
The genome of Kp BIC-1 was sequenced using PacBio RS technology (GATC Biotech AG, Mulhouse, France). Illumina whole-genome sequencing (WGS) was performed on Kp isolates BIC-1 and S1-S17. DNA libraries were prepared using the Nextera XT version 3 kit (Illumina, Essex, United Kingdom) and run on a MiSeq system to generate paired-end 75-or 150-bp reads. Kp BIC-1 genome was used as reference for detecting mutations using BRESEQ [16] . Acquisition of genetic material was assessed by analyzing unmapped reads following their de novo assembly by using Velvet [17] . Phylogeny of the 18 Kp isolates was constructed by considering the 85 identified single-nucleotide polymorphisms (SNPs) among their genomes by maximum parsimony using MEGA software [18] , refined manually and rooted by considering the direction of each SNP as described previously [19] . Evolutionary rate of the patient strain was determined based on the linear association between the root-to-tip number of mutations and year of strain isolation. The core genome phylogeny of the 18 Kp isolates together with ST258 published sequences and with the ST11 strain HS11286 as an outgroup was performed using the Parsnp program from the Harvest suite [20] .
Quantification of Biofilm Formation
Biofilm formation capacity was measured by microtiter plate as previously described [21] . In brief, 2.10 7 colony-forming units (CFU)/mL of an overnight culture was inoculated into 180 µL of medium M63B1-0.4% glucose in a 96-well polyvinyl chloride microtiter plate (Falcon). After 18 hours of incubation at 37°C, culture medium was removed, bacteria were fixed by adding 100 μL of Boin solution (Sigma-Aldrich, Saint Quentin Fallavier, France), and rinsed once with distilled water. Bacterial cells were stained for 10 minutes at room temperature by adding 50 µL of 0.5% (wt/vol) aqueous solution of crystal violet in each well and washed twice with distilled water and dried at room temperature. The bound dye was released from stained cells using 80/20 ethanol/acetone solution and measured by absorbance at 595 nm.
Serum Resistance Assay
The serum resistance of isolates S1, S11, S13, S15, S17, and Kp CIP53153 as reference were determined according to the method of Siu et al [22] . In brief, bacterial suspensions were collected from mid-log phase cultures (approximately 5.10 7 CFU/mL) and mixed at a 1:3 (vol/vol) ratio with pooled human serum (sterile and filtered human male AB plasma from SigmaAldrich) and incubated at 37°C with agitation. Colony counts were determined at time 0 and after 30, 60, 120, and 180 minutes of incubation. Serum susceptibility was assessed by plotting the average survival percentage against the incubation time. Each strain was tested 4 times.
Statistical Analysis
Statistical analysis was performed on ≥3 independent experiments using GraphPad Prism version 6 software. Data were compared 2-by-2 using unpaired Student t test with Welch correction. P values <.05 were considered statistically significant.
RESULTS

Clinical Case
In 2009, a nosocomial outbreak of KPC-Kp isolates mediated by a contaminated endoscope occurred in a French tertiary care hospital [12] . Seventeen patients who underwent gastroscopy were contaminated with an endoscope-borne KPC-Kp strain (Kp BIC-1). One of them suffered from recurrent cholangitis due to repetitive lithiasis ( Figure 1A ). In September 2009, he underwent sphincteroscopy with the contaminated endoscope. Until April 2014, 17 KPC-Kp isolates were collected from this patient (S1-S17) ( Table 1 ). In 2013, a prostatic adenocarcinoma and a bladder cancer were diagnosed. In 2014, infectious complications occurred a week after a cystoprostatectomy, with peritonitis secondary to a breach in the Bricker anastomosis. Sepsis secondary to a polymicrobial infection with intestinal bacteria including KPC-Kp was followed by multivisceral failure and death. 
Genetic Diversification of a Single KPC-Kp Strain
To demonstrate whether the patient was colonized by a single KPC-Kp strain, we performed Figure 1) [2, 23, 24] . SNP-based phylogeny of the 18 isolates showed that they represent a monophyletic clade ( Figure 1B) . Therefore, all the patients' isolates derived from Kp BIC-1.
Within-host colonization of this strain over 4.5 years led to the accumulation of mutations (deletions, tandem duplications, and SNPs) in up to 39, 24, and 22 loci for the last 3 isolates (S15, S16, and S17, respectively) ( Figure 1B) . Assembly of unmapped reads revealed no gene acquisition and a remarkably stable plasmid content over 4.5 years of carriage. A total of 98 genetic events occurred (Supplementary Table 2) , with most of them in the chromosome (n = 91). From this longitudinal study, we estimated that the average evolutionary rate of this KPC strain was of 7.5 SNPs per year per genome ( Figure 1C ).
Most significantly, the functions affected showed convergence toward specific pathways (Supplementary Table 2 ): (i) the respiratory chain: with 3 independent mutations in complex 1, heme biosynthesis, and in the sucC gene; (ii) anaerobic respiration with mutations in nitrate reductase genes, in the promoter region of the fnr gene encoding a regulator of anaerobic metabolism and in the narL regulatory gene; (iii) the metabolism of different carbon sources; and (iv) the cell envelope with mutations in porin genes (2 independent mutations in the ferric enterobactin receptor precursor, pfeA and an ompF-like gene), capsular polysaccharides (the glycosyl transferase epsJ, the colanic acid biosynthesis gene wcaJ, and the sensor histidine kinase rcsC), and the rfaH antiterminator.
Restoring Colistin Susceptibility
The patient received during these 4.5 years numerous antimicrobial treatments, including carbapenems and gentamicin ( Figure 1A) . Accordingly, we observed changes in the antibiotic susceptibility during colonization (Table 1 ). Kp BIC-1 isolated from the endoscope and the first 12 isolates from the patient (S1-S12) were resistant to colistin with MICs ≥64 mg/L (Table 1 ). This high level of resistance resulted from the insertion of ISKpn25 between nucleotides 141 and 142 of the mgrB gene. MgrB plays a prominent role in colistin resistance in Kp by repressing the PhoP-PhoQ regulatory pathway [25, 26] . PhoP indirectly activates the PmrA-PmrB 2-component system, which results in the overexpression of the arnBCADTEF operon leading to addition of the cationic groups (4-amino-4-deoxy-l-arabinose) on the phosphate groups of lipid A. This modification results in a decrease of the electronegative charge of the bacterial surface and resistance to cationic peptides [27] . After 2 years of carriage without any colistin treatment, all isolates (S13-S17) were susceptible to colistin (Table 1) . We identified 2 mutations in 2 partners of the colistin resistance pathway that may explain this phenotypic reversion. In 4 isolates (S13, S14, S16, and S17), we identified a mutation in arnC, leading to a nonconservative amino acid change, C161Y. ArnC is a lipid-A glycosyltransferase encoded by the arnBCADTEF operon. Isolate S15 is mutated in phoP (I201N). To investigate the effect of this SNP in PhoP, we quantified the expression of arnC, phoP, and phoQ genes (indirect and direct targets of PhoP) by qRT-PCR on strain S1 resistant to colistin, S15 (PhoP I201N), S17 (ArnC C161Y), and on 3 colistin-susceptible Kp strains used as reference (CIP 53153, YC2004, KN533). Compared to the reference strains, isolates S1 and S17 showed a significantly higher expression of arnC, confirming the effect of the mgrB disruption (Supplementary Figure 2) . In the S15 isolate mutated in PhoP, the expression of arnC, phoP, and phoQ was restored at the level of the reference colistin-susceptible strains (Supplementary Figure 2) . Regarding the S17 isolate, no change in the expression of arnC, phoP, and phoQ was observed as compared to S1. We therefore hypothesized that the mutation in arnC led to a decrease of the glycosyltransferase activity of the modified ArnC protein. To confirm the role of the SNPs in phoP and arnC in colistin susceptibility reversion, we complemented the phenotype of S15 and S17, respectively, by cloning the unmutated gene into a modified pUC19 vector (Supplementary Methods). Both complemented isolates S15-pUC19-phoP (wild-type [WT]) and S17-pUC19-arnC (WT) were resistant to colistin with MICs ≥32 µg/mL ( Table 2) .
Variation of Aminoglycoside Susceptibility
Kp BIC-1 and the first 6 isolates were susceptible to gentamicin, whereas 6 later isolates (S7-S11 and S15) shifted to gentamicin resistance and an increased susceptibility to amikacin (Table 1  and Supplementary Table 3 ). SNP analysis revealed the presence of a point mutation in the aac(6ʹ)-Ib gene carried by pBIC-1c, leading to a L119S amino acid change of the AAC(6ʹ)-Ib enzyme in all the gentamicin-resistant isolates. Casin et al showed that this substitution led similarly to an 8-fold decrease in amikacin MICs and to an 8-fold increase in gentamicin MICs [28] . By cloning the 2 aac(6ʹ)-Ib variants in Escherichia coli, the involvement of this SNP for the gentamicin resistance switch was demonstrated (Supplementary Table 3 ).
Strain Adaptation to Promote Virulence
Specific adaptation that could promote bacterial virulence during long-term carriage was investigated. A feature of KPC-Kp ST258 isolates is their ability to cause bacteremia, especially in immunocompromised patients [29] . Among the 17 isolates, S15 was responsible for a bloodstream infection. To assess if some polymorphisms in S15 might have contributed to its ability to grow in blood, we performed serum resistance assay on 5 isolates from the patient and on the non-ST258 Kp CIP 53153 strain as reference. Isolates S1, S11, S13, S17, and CIP 53153 were highly sensitive to serum, but isolate S15 was not only resistant to human serum but also grew rapidly (Figure 2 ). An SNP responsible for a nonsense mutation was present in the gmlC gene only in this isolate. The gml operon is present in the vast majority of KPC-Kp ST258 strains and is known to confer improved survival in the presence of human serum [30] . However, cloning experiment of a WT copy of gmlC in S15 could not restore susceptibility to human serum (Supplementary Methods). The reasons for S15's peculiar phenotype might reside in 1 or several of the other 35 unique mutations.
A second common feature of KPC-Kp ST258 is its low capacity to produce biofilm [31] . However, mutations in type 1 fimbriae operon potentially implicated in biofilm production [32] were detected in several isolates. Indeed, whereas the Kp BIC-1 strain and 16 isolates were poor biofilm producers, the isolate S7 produced significantly more biofilm ( Figure 3A) . We have detected 3 differences in the genome of S7 compared to Kp BIC-1 (Supplementary Table 2 ), including an inversion of the fim element in the promoter region switching from off to on the expression of the type 1 fimbriae operon ( Figure 1C ) and a nonsynonymous SNP (P180T) in the fimH gene encoding the fimbriae adhesin.
Isolates S6, S8, S9, S10, S15, and S17 possess also an insertion of an adenosine in the fim element ( Figure 3B ) but no significant difference in biofilm formation ( Figure 3A) . To investigate the effect of these genomic modifications on the expression of the type 1 fimbriae, we performed qRT-PCR on isolates Kp BIC-1, S6, and S7 (Supplementary Materials). Compared to Kp BIC-1, we observed 11-and 71-fold increase in the expression of the fimH gene in S6 and in S7, respectively ( Figure 3C ). Although the 11-fold increase in fimH expression has no detectable effect on biofilm production under laboratory conditions, it might increase adhesion to host cells and contribute to virulence or colonization [33] .
DISCUSSION
Here, we deciphered by WGS the within-patient evolution of a single strain of KPC-Kp over 4.5 years. The study begins with a rare but dramatic case of nosocomial transmission of carbapenemase-producing Enterobacteriaceae due to a contaminated endoscope, and ends prematurely with the patient's death secondary to a sepsis with the same KPC-Kp. The evolutionary rate was calculated at 7.5 SNPs per year per genome, but this value needs to be considered with caution as the patient received several courses of antimicrobial treatments and, thus, the selective pressure was not constant. This value is between the rate of 3.8 SNPs per year observed in a study of multidrug-resistant (MDR) Kp in Ireland and the United Kingdom [34] and a rate of 10 mutations per genome per year determined in KPC-Kp from a single institution [35] .
We therefore analyzed the phenotypic diversification related to antimicrobial pressure. Regarding aminoglycoside susceptibility, we reported a in vivo mutation in the aac(6ʹ)-Ib gene that conferred resistance to gentamicin. It appeared subsequent to a 10-day treatment with imipenem and gentamicin, and was stable over time. This highlights the risk of rapid change in the specificity of AAC(6ʹ)-Ib and its possible implication in treatment failures. Strikingly, the contaminating strain was colistin resistant but after 2 years of carriage, all isolates became susceptible to colistin. The in vivo reversion from a resistant to a susceptible phenotype has been reported in Acinetobacter baumannii and in Pseudomonas aeruginosa but not yet in Kp [27] . Colistin is currently one of a Klebsiella pneumoniae (Kp) 53153 is a non-K. pneumoniae carbapenemase non-ST258 strain. All strains were compared to the strain S17. *P < .05; **P < .01; ***P < .001, all Student t test. the last-resort treatments for severe human infections caused by MDR bacteria, particularly carbapenemase-producing Enterobacteriaceae [7] . Even though plasmid-mediated colistin resistance mcr genes have recently been described worldwide [36, 37] , high-level colistin resistance in Enterobacteriaceae in human is still mainly due to nontransferable modifications of the lipid A resulting from chromosomal mutations [27] . After 2 years of intestinal carriage without colistin pressure, we identified 2 compensatory mutations in the clinical isolates, highlighting the potential impact of lipid A modifications on bacterial in vivo fitness, similar to what was observed for colistin-resistant A. baumannii both in vitro and in vivo [38] .
To further explore the long-term adaptation of this clone, mutations that could impact bacterial virulence were searched for. An inversion in the promoter region of the fim locus was found in isolate S7 capable to produce significantly more biofilm than others. A search for the orientation of the fim element in KPC-Kp CG258 genome sequences available on public repositories revealed that of >500 strains, only 3 were oriented to allow expression of the fim operon. Therefore, expression of the type 1 fimbriae seems extremely rare in KPC-Kp ST258 and might have been selected under long-term colonization. Furthermore, isolate S15 showed a unique evolutionary trajectory in the patient, as it did not share any common SNPs with the previous nor the 2 following isolates and had 39 genomic differences with BIC-1 ( Figure 1B and Supplementary Table 2 ). This isolate is therefore a proof of the genomic diversity that occurred in vivo during persistent carriage, leading to a broad range of adaptive phenotypes contributing to invasive infection. The S15 strain, isolated almost 3 years after infection, acquired the ability to grow in serum, to be resistant to gentamicin, and to reverse the colistin resistance phenotype. The diversity of isolates revealed a complex within-host evolution involving possibly adaptation to specific niches in the gut and leading to a diverse clonal population only partially characterized by the conservation of a single isolate at each sampling.
In summary, our work highlights the importance of leveraging the power of WGS to better understand how clinically important clones are capable to adapt and cause disease in the human host. Currently, no specific clinical guidelines The dotted line corresponds to the mean absorbance of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-Kp) strains S1-S6 and S8-S17. Only the absorbance of the S7 strain is significantly increased compared to the other KPC-Kp strains. ****P < .0001, Student t test. LM21 was used as a control positive strain [37] . In C-, no bacteria were added in the well. B, Analysis of fimH expression using quantitative reverse-transcription polymerase chain reaction (n = 3, mean of fold change expression ± SEM) *P < .05 Student t test. C, Schematic representation of the fim locus in the 18 isolates. The white and gray arrows indicate right and left inverted repeats, respectively.
recommend the typing of >1 isolate per patient, but our findings reveal the need to closely consider within-host variability in future studies of K. pneumoniae evolution and transmission.
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